Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02678572
Title Percutaneous Hepatic Perfusion vs Best Alternative Care in Patients With Hepatic-dominant Ocular Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Delcath Systems Inc.
Indications
Therapies

Dacarbazine

Ipilimumab

Melphalan

Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.